Carlo Selmi is the Head of the Rheumatology and Clinical Immunology Unit at the Humanitas Research Hospital in Milan, Italy. He earned his MD degree (1998) and his PhD degree in internal medicine (2002) at the University of Milan and spent four years as a post-doctoral researcher in the Division of Rheumatology, Allergy, and Clinical Immunology at the University of California at Davis (UC Davis) in Davis, CA, USA (2001–2004). Between 2005 and 2014, he worked as Assistant Adjunct Professor of Medicine in the same division at UC Davis. Professor Selmi has also held the positions of Assistant Professor of Internal Medicine (since 2006) and Rheumatology (2011–2019) at the University of Milan. In 2019, he was appointed Associate Professor of Internal Medicine at Humanitas University in Milan.
Professor Selmi’s research track is dedicated to organ-specific and systemic autoimmune and chronic inflammatory diseases, including the clinical epidemiology and pathogenetic mechanisms of autoimmune liver disease, connective tissue disease (particularly systemic sclerosis), and psoriatic arthritis. His team at Humanitas comprises a group of young physician scientists with wide research and clinical expertise, including periods working at foreign institutions. They hold dedicated clinics for rheumatoid arthritis, spondyloarthritis, and connective tissue disease, including systemic sclerosis and systemic lupus erythematosus, and are active with articular ultrasound, videocapillaroscopy, arthrocentesis and intra-articular injections.
Professor Selmi has coauthored over 330 peer-reviewed publications with a Scopus H index of 58 and a total impact factor exceeding 2,500. His work has been funded by the National Institutes of Health, American Liver Foundation, American Scleroderma Foundation, Italian Ministry of Health, Italian Ministry of Foreign Affairs, and the Lilly Research Foundation.
EM-38478 - Date of preparation: January 2021